HPR60 What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.784
https://www.valueinhealthjournal.com/article/S1098-3015(25)00909-X/fulltext
Title :
HPR60 What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)00909-X&doi=10.1016/j.jval.2025.04.784
First page :
Section Title :
Open access? :
No
Section Order :
10509